Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|September 10, 2017
Significance of perivascular tumour cells defined by CD109 expression in progression of gliomaYukihiro Shiraki, Shinji Mii, Atsushi Enomoto, et al.
Brain Tumor Pathology|November 26, 2021
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomasTomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, et al.
ACS Applied Materials & Interfaces|April 1, 2021
Urinary MicroRNA-Based Diagnostic Model for Central Nervous System Tumors Using Nanowire ScaffoldsYotaro Kitano, Kosuke Aoki, Fumiharu Ohka, et al.
Acta Neuropathologica Communications|February 27, 2025
Imaging features and consideration of progression pattern of diffuse hemispheric gliomas, H3 G34-mutantYuji Kibe, Lushun Chalise, Fumiharu Ohka, et al.
Iscience|March 1, 2021
Neurod4 converts endogenous neural stem cells to neurons with synaptic formation after spinal cord injuryToshiki Fukuoka, Akira Kato, Masaki Hirano, et al.
Biosensors & Bioelectronics|May 12, 2023
Mutation detection of urinary cell-free DNA via catch-and-release isolation on nanowires for liquid biopsyHiromi Takahashi, Takao Yasui, Masaki Hirano, et al.
Blood Advances|September 28, 2021
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemiaHironobu Kitazawa, Yusuke Okuno, Hideki Muramatsu, et al.
Acta Neuropathologica Communications|February 6, 2020
H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutantSachi Maeda, Fumiharu Ohka, Yusuke Okuno, et al.
Neuro-Oncology|July 2, 2021
Newly established patient-derived organoid model of intracranial meningiomaShintaro Yamazaki, Fumiharu Ohka, Masaki Hirano, et al.
Pageof 8